Page last updated: 2024-11-05

octamethylenediamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Octamethylenediamine, also known as 1,8-octanediamine, is a colorless liquid with a strong amine odor. It is a versatile building block in the synthesis of polymers, pharmaceuticals, and other chemicals. Octamethylenediamine can be synthesized through various methods, including the reduction of 1,8-octanedinitrile or the reaction of 1,8-octanediol with ammonia. It is known for its high reactivity due to the presence of two primary amine groups. Octamethylenediamine is commonly used in the production of nylon-8, a high-performance polymer with excellent strength, toughness, and heat resistance. This compound is studied for its potential applications in various fields, including the development of novel polymers, catalysts, and pharmaceuticals.'

octamethylenediamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,8-diaminooctane : An alkane-alpha,omega-diamine in which the two amino groups are separated by eight methylene groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24250
CHEMBL ID29392
CHEBI ID73112
SCHEMBL ID35706
MeSH IDM0052766

Synonyms (50)

Synonym
7613-16-3
373-44-4
octamethylenediamine
1,8-diaminooctane
einecs 206-764-3
brn 1735426
1,8-diaminooctane, 98%
DB04333
1,8-octylenediamine
1,8-octamethylenediamine
octane 1,8-diamine
1,8-octanediamine
27ADC60C-8497-49F5-9025-5A855BA566E6
octane, 1,8-diamino-
D0107
CHEMBL29392 ,
chebi:73112 ,
diaminooctane
bdbm50129716
octane-1,8-diamine
53a6694pie ,
ec 206-764-3
unii-53a6694pie
3-04-00-00612 (beilstein handbook reference)
AKOS006223685
alpha,omega-diaminooctane
FT-0607035
SCHEMBL35706
1,8-diamino-n-octane
.alpha.,.omega.-octanediamine
octamethylene diamine
1,8-octane diamine
1,8-diamino octane
1.8-diaminooctane
1,8 diaminooctane
W-106546
1,4-octanediamine
DTXSID9073173
STL495623
mfcd00008248
F21311
1-8-diaminooctane
1,8-diaminooctane; octamethylenediamine; 1,8-octanediamine
CS-W016375
Q27095148
AS-14372
BBL037236
EN300-211827
SB75550
Z1203577927
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkane-alpha,omega-diamineA primary diamine that is ethane or a higher alkane in which a hydrogen of each of the terminal methyl groups has been replaced by an amino group. H2NCH2(CH2)nCH2NH2, where n = 0, 1, 2, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyamine oxidase 1Zea maysKi0.30000.00751.10253.0000AID419311
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID343354Cytotoxicity against mouse 3LL CRL 1642 cells after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID448531Cytotoxicity against mouse J774 macrophage assessed as cell viability at 100 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID448530Cytotoxicity against mouse J774 macrophage assessed as cell viability at 10 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID448532Cytotoxicity against Mycobacterium bovis Bacillus Calmette-Guerin infected mouse J774 macrophage assessed as cell viability at 1 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID343352Cytotoxicity against CHO cells after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID343356Cytotoxicity against human MCF7 ATCC HTB 22 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID343355Cytotoxicity against human DU145 ATCC HTB 81 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID343351Cytotoxicity against mouse L1210 ATCC CCL 219 cells after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID343357Cytotoxicity against human K562 ATCC CCL 243 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID448534Cytotoxicity against Mycobacterium bovis Bacillus Calmette-Guerin infected mouse J774 macrophage assessed as cell viability at 100 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID343353Cytotoxicity against polyamine transport-deficient mutant CHO cells after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID448381Cytotoxicity against mouse J774 macrophage assessed as cell viability at 1 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID343358Cytotoxicity against human U251 RCB 0641 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and cytotoxic activities of usnic acid derivatives.
AID448533Cytotoxicity against Mycobacterium bovis Bacillus Calmette-Guerin infected mouse J774 macrophage assessed as cell viability at 10 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID100047Tested for the T/C (survival time treated/survival time control x 100) after intraperitoneal administration of 50 mg/Kg in 10 E 5 L1210 cells on day 0; not active1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Polyamine analogues with antitumor activity.
AID419311Inhibition of maize PAO at pH 6.5 by spectrophotometry-based Dixon plot method2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Synthesis and biological evaluation of guanidino compounds endowed with subnanomolar affinity as competitive inhibitors of maize polyamine oxidase.
AID160317Binding affinity to the mouse polyamine transporter on the L1210 cell surface2003Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates.
AID448380Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as minimum inhibitory concentration after 24 hrs by micro plate Alamar blue assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.00)18.7374
1990's3 (15.00)18.2507
2000's8 (40.00)29.6817
2010's6 (30.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.21 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]